https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-october-23-2026/ 2026-10-23T21:08:12Z Pharminent en GLP-1 Competitive Market Digest • Weekly • October 23, 2026 2026-10-23T21:08:12Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-october-23-2026/ 2026-10-23T16:45:51Z Pharminent en Strategic News Watch • October 23, 2026 2026-10-23T16:45:51Z Blog https://pharminent.com/moderna-and-mercks-melanoma-vaccine-cuts-recurrence-risk-42/ 2026-10-23T11:45:58Z Pharminent en Moderna and Merck's melanoma vaccine cuts recurrence risk 42% 2026-10-23T11:45:58Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-october-22-2026/ 2026-10-23T02:48:45Z Pharminent en Rare Disease & Gene Therapy Digest • October 22, 2026 2026-10-23T02:48:45Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-october-21-2026/ 2026-10-22T15:01:31Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • October 21, 2026 2026-10-22T15:01:31Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-october-21-2026/ 2026-10-22T15:00:59Z Pharminent en Manufacturing Intelligence • Weekly Digest • October 21, 2026 2026-10-22T15:00:59Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-october-22-2026/ 2026-10-22T14:59:58Z Pharminent en Strategic News Watch • October 22, 2026 2026-10-22T14:59:58Z Blog https://pharminent.com/fda-approves-gsks-hepatitis-b-drug-hibsago-licensed-from-ionis/ 2026-10-22T11:45:57Z Pharminent en FDA approves GSK's hepatitis B drug Hibsago licensed from Ionis 2026-10-22T11:45:57Z Blog